Interactive Effect of Paraoxonase-1 Q192R Polymorphism and Smoking History on the Lung Function Decline in Grain Workers

Annals of Epidemiology

Volumn 18, Issue 4, 2008, Pages 330-334

  Seo, Takayuki ^a   Pahwa, Punam ^b   McDuffie, Helen H ^b   Nakada, Naoyuki ^b   Goto, Shuji ^a   Ghosh, Sunita ^b   Nakagawa, Kazuko ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Genetic Polymorphism; Lung Function Decline; Paraoxonase 1; Smoking

Indexed keywords

ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE 1; HIGH DENSITY LIPOPROTEIN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; ENZYME POLYMORPHISM; FORCED EXPIRATORY VOLUME; GENE; GENE INTERACTION; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; LUNG FUNCTION; MALE; OCCUPATIONAL HEALTH; PON1 GENE; PRIORITY JOURNAL; SMOKING; STATISTICAL SIGNIFICANCE;

ADULT; AGRICULTURE; ARYLDIALKYLPHOSPHATASE; CEREALS; FORCED EXPIRATORY VOLUME; GLUTAMINE; HUMANS; LONGITUDINAL STUDIES; LUNG; MALE; POLYMORPHISM, GENETIC; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SASKATCHEWAN; SMOKING; UNITED STATES;

EID: 40949128776     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2007.10.002     Document Type: Article

References (15)

1. Kinnula V.L. Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases. Thorax 60 (2005) 693-700
2. Hang J., Zhou W., Wang X., Zhang H., Sun B., Dai H., et al. Microsomal epoxide hydrolase, endotoxin, and lung function decline in cotton textile workers. Am J Respir Crit Care Med 171 (2005) 165-170
3. He J.Q., Connett J.E., Anthonisen N.R., Pare P.D., and Sandford A.J. Glutathione S-transferase variants and their interaction with smoking on lung function. Am J Respir Crit Care Med 170 (2004) 388-394
4. Seo T., Pahwa P., McDuffie H.H., Shindo J., Goto S., Hashimoto M., et al. Association between paraoxonase-1 Q192R polymorphism and lung function among Saskatchewan grain handlers. Pharmacogenomics 8 (2007) 901-908
5. Deakin S.P., and James R.W. Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1. Clin Sci (Lond) 107 (2004) 435-447
6. Rodrigo L., Hernandez A.F., Lopez-Caballero J.J., Gil F., and Pla A. Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue. Implications for its physiological role. Chem Biol Interact 137 (2001) 123-137
7. Aviram M., Hardak E., Vaya J., Mahmood S., Milo S., Hoffman A., et al. Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation 101 (2000) 2510-2517
8. Pahwa P., Senthilselvan A., McDuffie H.H., and Dosman J.A. Longitudinal decline in lung function measurements among Saskatchewan grain workers. Can Respir J 10 (2003) 135-141
9. American Thoracic Society. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 152 (1995) 1107-1136
10. Liang K.Y., and Zeger S.L. Longitudinal data analysis using generalized linear models. Biometrika 73 (1986) 13-22
11. Wise R.A. The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression. Am J Med 119 Suppl 1 (2006) 4-11
12. Stoltz D.A., Ozer E.A., Ng C.J., Yu J.M., Reddy S.T., Lusis A.J., et al. Paraoxonase-2 deficiency enhances Pseudomonas aeruginosa quorum sensing in murine tracheal epithelia. Am J Physiol Lung Cell Mol Physiol 292 (2007) L852-L860
13. Prescott E., Lange P., and Vestbo J. Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study. Eur Respir J 13 (1999) 1109-1114
14. La Du B.N., Aviram M., Billecke S., Navab M., Primo-Parmo S., Sorenson R.C., et al. On the physiological role(s) of the paraoxonases. Chem Biol Interact 119-120 (1999) 379-388
15. Draganov D.I., and La Du B.N. Pharmacogenetics of paraoxonases: a brief review. Naunyn Schmiedebergs Arch Pharmacol 369 (2004) 78-88